Outpatient, combined use of opioid and benzodiazepine medications in the United States, 1993–2014
The combined use of opioid and benzodiazepine medications increases the risk of hazardous effects, such as respiratory depression. Although recent increases in outpatient use of opioid prescriptions have been documented, there are limited data regarding rates and correlates of combined opioid and be...
Main Authors: | Matthew E. Hirschtritt, Kevin L. Delucchi, Mark Olfson |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-03-01
|
Series: | Preventive Medicine Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211335517301857 |
Similar Items
-
Analysis of psychiatrists’ prescription of opioid, benzodiazepine, and buprenorphine in Medicare Part D in the United States
by: Kevin Pan, et al. -
Co-prescription of opioids with benzodiazepine and other co-medications among opioid users: differential in opioid doses
by: Zin CS, et al.
Published: (2017-01-01) -
A descriptive analysis of concomitant opioid and benzodiazepine medication use and associated adverse drug events in United States adults between 2009 and 2018
by: Kathryn K. Marwitz, et al.
Published: (2022-03-01) -
Anhedonia modulates benzodiazepine and opioid demand among persons in treatment for opioid use disorder
by: Mark K. Greenwald, et al.
Published: (2023-01-01) -
Pattern of Benzodiazepine use in Outpatients in Mashad, Iran
by: SH Saeidinejat, et al.
Published: (2011-09-01)